NCT00240721View on ClinicalTrials.gov

A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

363

Participants

Timeline

Start Date

October 31, 2000

Study Completion Date

September 30, 2002

Conditions

Bipolar DisordersMood DisordersAffective Disorders, Psychotic

Interventions

DRUG

topiramate

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00240721 - A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder | Biotech Hunter | Biotech Hunter